Effects of progesterone on hippocampal ultrastructure and expression of inflammatory mediators in neonatal rats with hypoxic-ischemic brain injury

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1311-1316

  Li, Xiaojuan ^a   Zhang, Junhe ^a   Zhu, Xiaoqian ^a   Hou, Ruanling ^a   Li, Xinjuan ^a   Dong, Xianhong ^a   Wang, Xiaoyin ^a   Lu, Chengbiao ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Brain damage; Hypoxia ischemia; Nuclear factor B; Progesterone; Tumor necrosis factor ; Ultrastructure

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY LIGATION; CELL ULTRASTRUCTURE; COMMON CAROTID ARTERY; CONTROLLED STUDY; HIPPOCAMPUS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84896898922     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1589     Document Type: Article

References (38)

1. Doi K, Sameshima H, Kodama Y, Furukawa S, Kaneko M and Ikenoue T; Miyazaki Perinatal Data Groups: Perinatal death and neurological damage as a sequential chain of poor outcome. JMatern Fetal Neonatal Med 25: 706-709, 2012.
2. Northington FJ, Chavez Valdez R and Martin LJ: Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 69: 743-758, 2011.
3. Vannucci SJ and Hagberg H: Hypoxia-ischemia in the immature brain. J Exp Biol 207: 3149-3154, 2004.
4. Sasaoka N, Kawaguchi M, Kawaraguchi Y, et al: Isoflurane exerts a short-term but not a long-term preconditioning effect in neonatal rats exposed to a hypoxic-ischaemic neuronal injury. Acta Anaesthesiol Scand 53: 46-54, 2009.
5. Boggio PS, Coutinho de Macedo E, Pascual-LeoneA, TormosMuñoz JM, Schwartzman JS and Fregni F: Neuromodulation in hypoxic-ischemic injury. Brain Stimul2: 179-181, 2009.
6. Zhao P and Zuo Z: Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 101: 695-703, 2004.
7. Liu F and McCullough LD: Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol Sin 34: 1121-1130, 2013.
8. Kasdorf E and Perlman JM: Hyperthermia, inflammation, and perinatal brain injury. Pediatr Neurol 49: 8-14, 2013.
9. Bonestroo HJ, Nijboer CH, van Velthoven CT, Kavelaars A, Hack CE, van Bel F and Heijnen CJ: Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats. Dev Neurosci 35: 197-211, 2013.
10. Walberer M, Rueger MA, Simard ML, Emig B, Jander S, FinkGR and Schroeter M: Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns. Exp Transl Stroke Med2: 22, 2010.
11. Baker SJ and Reddy EP: Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261-3270, 1998.
12. Chung HS, Kim SN, Jeong JH and Bae H: A novel synthetic compound 4-acetyl-3-methyl-6-(2-bromophenyl)pyrano[3,4-c]pyran-1,8-dione inhibits the production of nitric oxide and proinflammatory cytokines via the NF-κB pathway in lipopolysaccharide-activated microglia cells. Neurochem Res38: 807-814, 2013.
13. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F and Kavelaars A: A dual role of the NF-kappa B pathway in neonatal hypoxic-ischemic brain damage. Stroke 39: 2578-2586, 2008.
14. Su JR, Zhao ZC, Chen WL and Wang X: The effect of activated nuclear factor-kappaB in pathogenesis of acute pancreatitis. Zhonghua Yi Xue Za Zhi83: 1497-1500, 2003 (In Chinese).
15. Gesslein B, Håkansson G, Gustafsson L, Ekström P and MalmsjöM: Tumor necrosis factor and its receptors in the neuroretina and retinal vasculature after ischemia-reperfusion injury in the pig retina. Mol Vis 16: 2317-2327, 2010.
16. Pettus EH, Wright DW, Stein DG and Hoffman SW: Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049: 112-119, 2005.
17. Singh M and Su C: Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy. Brain Res1514: 98-106, 2013.
18. Baudry M, Bi X and Aguirre C: Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience239: 280-294, 2013.
19. Li DL, Zhao HG, Wang DX and Ding YF: Effect of progesterone on cerebral cortex edema in rats exposed to focal ischemia/reperfusion. Zhongguo Ying Yong Sheng Li Xue Za Zhi 17: 327-329, 2001 (In Chinese).
20. Li DL and Han H: Effect of progesterone on the expression of GLUT in the brain following hypoxic-ischemia in newborn rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 24: 353-355, 2008 (In Chinese).
21. Wang X, Zhang J, Yang Y, Dong W, Wang F, Wang L and LiX: Progesterone attenuates cerebral edema in neonatal rats with hypoxic-ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4. Exp Ther Med6: 263-267, 2013.
22. Rice JE 3rd, Vannucci RC and Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9: 131-141, 1981.
23. Taniguchi H and Andreasson K: The hypoxic-ischemic encephalopathy model of perinatal ischemia. J Vis Exp 19: 955, 2008.
24. Chen G, Shi J, Ding Y, Yin H and Hang C: Progesterone prevents traumatic brain injury-induced intestinal nuclear factor kappaB activation and proinflammatory cytokines expression in male rats. Mediators Inflamm 2007: 93431, 2007.
25. Sarkaki AR, Khaksari Haddad M, Soltani Z, Shahrokhi N and Mahmoodi M: Time-and dose-dependent neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury. J Neurotrauma 30: 47-54, 2013.
26. Aggarwal R, Medhi B, Pathak A, Dhawan V and ChakrabartiA: Neuroprotective effect of progesterone on acute phase changes induced by partial global cerebral ischaemia in mice. J Pharm Pharmacol 60: 731-737, 2008.
27. Tsuji M, Taguchi A, Ohshima M, Kasahara Y and IkedaT: Progesterone and allopregnanolone exacerbate hypoxic-ischemic brain injury in immature rats. Exp Neurol 233: 214-220, 2012.
28. Gustavsson M, Wilson MA, Mallard C, Rousset C, JohnstonMV and HagbergH: Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms? Pediatr Res61: 444-450, 2007.
29. Rouse DJ, Hirtz DG, Thom E, et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network: A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359: 895-905, 2008.
30. O'Connor JJ: Targeting tumour necrosis factor-α in hypoxia and synaptic signalling. Ir J Med Sci 182: 157-162, 2013.
31. Barone FC, Arvin B, White RF, et al: Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28: 1233-1244, 1997.
32. Guo M, Lin V, Davis W, et al: Preischemic induction of TNF-alpha by physical exercise reduces blood-brain barrier dysfunction in stroke. J Cereb Blood Flow Metab 28: 1422-1430, 2008.
33. Sen R and Baltimore D: Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappaB by posttranslational mechanism. Cell 47: 921-928, 1986.
34. Kaufmann JA, Bickford PC and Taglialatela G: Free radical-dependent changes in constitutive Nuclear factor kappaB in the aged hippocampus. Neuroreport 13: 1917-1920, 2002.
35. Lee HJ, Oh TH, Yoon WJ, et al: Eutigoside C inhibits the production of inflammatory mediators (NO, PGE(2), IL-6) by down-regulating NF-kappaB and MAP kinase activity in LPS-stimulated RAW 264.7 cells. J Pharm Pharmacol 60: 917-924, 2008.
36. Brown KD, Claudio E and Siebenlist U: The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther10: 212, 2008.
37. Hayden MS and Ghosh S: Shared principles in NF-kappaB signaling. Cell 132: 344-362, 2008.
38. Wang X, Zhang J, Si D, et al: Progesterone inhibits the expression of cycloxygenase-2 and interleukin-1β in neonatal rats with hypoxic ischemic brain damage. Int J Neurosci 124: 42-48, 2014.